Vivus Wins US Approval to Sell New Diet Drug Qsymia Vivus also must perform post-approval safety studies, including research to assess cardiovascular risk of taking the diet drug. Last month, the FDA approved Arena's diet pill Belviq for sale in the US, making it the first new weight loss drug approved in ... 07/18/2012 - 1:29 am | View Link
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ... 07/17/2012 - 12:32 pm | View Link
Vivus Wins FDA Approval MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ... 04/30/2012 - 9:07 am | View Link
Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ... 04/27/2012 - 1:00 pm | View Link
Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges Trading in Vivus stock was halted yesterday before the FDA panel vote. NeuroSearch, which is developing tesofensine for obesity, climbed 5.6 percent to 17 kroner and Novo Nordisk, which is studying its Victoza diabetes drug as a weight-loss treatment ... 02/22/2012 - 11:00 am | View Link
VVUS Up to date analysis of Vivus, Inc. (VVUS) and its stock by hedge fund managers and industry experts. Find out what Vivus, Inc. is saying about its business from the ... 08/1/2014 - 4:05 pm | View Website
Homepage The Burrill Report ... By the numbers Sage Therapeutics Scores $90M in Upsized IPO. At a time when many biotech stocks fell on Federal Reserve Chairwoman Janet Yellen ... 08/1/2014 - 3:15 pm | View Website
FDA's Top Q4 Blockbuster Drug Decisions The FDA has some of its biggest decisions of the year looming in the next few months. The first new lupus drug in half a century, a blood-thinner with mega ... 08/1/2014 - 7:23 am | View Website
BioWorld | The Daily Biopharmaceutical News Source Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use. 08/1/2014 - 4:10 am | View Website
VIVUS Qsymia Patents: Intellectual Property House of Cards ... Robert Diggs Deeper: Is Vivus Worth more than $0.24 Per Share? What is new in the report? A prior art challenge I filed against a pending Qsymia patent in ... 07/28/2014 - 5:19 am | View Website
TUCSON, Ariz. — Arizona executioners injected Joseph Rudolph Wood with a lethal combination of drugs 15 times during the nearly two hours it took for him to die, according to documents released Friday.
California prison officials are pledging to take a more gentle approach with mentally ill inmates after graphic images of prisoners being repeatedly doused with pepper spray in their cells were made public several months ago.
CEDAR RAPIDS — As bad as it is, Lawrence Lessig has no reservations about using a bad, unjust — some say corrupt — campaign finance system to change the way campaigns are funded.“We’re taking advantage of a system we want changed to bring about change,” the founder and chairman of Mayday Political Action Committee says.